News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
LifeCycle Pharma Achieved Strong Progress in its Pipeline
May 14, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HØRSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX:LCP) today announced the Interim Report for the 3 months ended March 31, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
Europe
MORE ON THIS TOPIC
Antibody-drug conjugate (ADC)
BioNTech, DualityBio tout ‘clinically meaningful’ efficacy for ADC in mid-stage endometrial cancer trial
April 13, 2026
·
2 min read
·
Tristan Manalac
Lymphoma
Allogene stock sails after CAR T clears residual lymphoma in early data cut
April 13, 2026
·
3 min read
·
Gabrielle Masson
Pancreatic cancer
Revolution rises 40% as pancreatic cancer drug doubles survival
April 13, 2026
·
2 min read
·
Annalee Armstrong
Cancer
IDEAYA and Servier’s eye cancer drug heads to FDA after delivering ‘best in class’ efficacy
April 13, 2026
·
2 min read
·
Heather McKenzie
